发明名称 Extracellular matrix cancer vaccine adjuvant
摘要 Compositions suitable for use as adjuvants in the preparation of vaccines, particularly those vaccines useful in the treatment of cancer, are provided. Methods for inhibiting tumor growth in an animal are also disclosed. Methods for immunizing an animal against cancer, such as prostate cancer, are also described. The adjuvants described are comprised of an extracellular matrix material, such as small intestinal submucosal (SIS) tissue. The preparations may take the form of sheets, gels, liquids (injectable), trocar, or other solid or semi-solid preparation. The invention provides for enhanced tumor inhibition of 2-fold or greater, compared to vaccine preparations without the extracellular matrix material, or from 4- to 5-fold, compared to preparations without the adjuvant promoting extracellular materials.
申请公布号 US8778360(B2) 申请公布日期 2014.07.15
申请号 US200611583771 申请日期 2006.10.20
申请人 University of Notre Dame 发明人 Suckow Mark A.;Wolter William R.
分类号 A61K9/00;A61K9/14;A61K9/70 主分类号 A61K9/00
代理机构 Husch Blackwell LLP 代理人 Husch Blackwell LLP ;Mayfield Denise L.
主权项 1. A composition comprising a tumor tissue cell suspension comprising replication incompetent tumor cells, and an adjuvant comprising extracellular matrix from a non-tumor source.
地址 Notre Dame IN US